BR112022024278A2 - Dispositivos de teste de diagnóstico legível por máquina e métodos e aparelho para fazer e/ou processar os mesmos - Google Patents

Dispositivos de teste de diagnóstico legível por máquina e métodos e aparelho para fazer e/ou processar os mesmos

Info

Publication number
BR112022024278A2
BR112022024278A2 BR112022024278A BR112022024278A BR112022024278A2 BR 112022024278 A2 BR112022024278 A2 BR 112022024278A2 BR 112022024278 A BR112022024278 A BR 112022024278A BR 112022024278 A BR112022024278 A BR 112022024278A BR 112022024278 A2 BR112022024278 A2 BR 112022024278A2
Authority
BR
Brazil
Prior art keywords
making
methods
processing
machine readable
testing devices
Prior art date
Application number
BR112022024278A
Other languages
English (en)
Portuguese (pt)
Inventor
Tu Hellmich-Duong Thanh
Uhlig Thomas
Buenning Carsten
Ullrich Thomas
Kügler Stefan
Klemm Heidi
Smit Chris
Original Assignee
Abbott Rapid Diagnostics Int Unlimited Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Rapid Diagnostics Int Unlimited Company filed Critical Abbott Rapid Diagnostics Int Unlimited Company
Publication of BR112022024278A2 publication Critical patent/BR112022024278A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/549—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic with antigen or antibody entrapped within the carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04W—WIRELESS COMMUNICATION NETWORKS
    • H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
    • H04W4/80—Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
BR112022024278A 2020-05-29 2021-05-31 Dispositivos de teste de diagnóstico legível por máquina e métodos e aparelho para fazer e/ou processar os mesmos BR112022024278A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063032093P 2020-05-29 2020-05-29
US202063129375P 2020-12-22 2020-12-22
PCT/EP2021/064581 WO2021240020A2 (en) 2020-05-29 2021-05-31 Machine readable diagnostic test devices and methods and apparatus to make and/or process the same

Publications (1)

Publication Number Publication Date
BR112022024278A2 true BR112022024278A2 (pt) 2023-02-07

Family

ID=76392338

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022024278A BR112022024278A2 (pt) 2020-05-29 2021-05-31 Dispositivos de teste de diagnóstico legível por máquina e métodos e aparelho para fazer e/ou processar os mesmos

Country Status (7)

Country Link
US (1) US20230221312A1 (https=)
EP (1) EP4158342B1 (https=)
JP (1) JP7748972B2 (https=)
KR (1) KR20230029684A (https=)
CN (1) CN116194778A (https=)
BR (1) BR112022024278A2 (https=)
WO (1) WO2021240020A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12321799B2 (en) * 2020-05-01 2025-06-03 Packaging Innovation, S. De R.L. Product authentication and product viewing system
US12607594B2 (en) * 2020-09-03 2026-04-21 Texas Instruments Incorporated ISFET biosensor
GB2604367A (en) * 2021-03-03 2022-09-07 Biotip Ltd Devices and methods for performing lateral flow tests
JP2023111040A (ja) * 2022-01-31 2023-08-10 株式会社エヌエフホールディングス 被験抗原または被験抗体の検査のための測定装置および測定方法
WO2023168519A1 (en) * 2022-03-07 2023-09-14 Roshan Water Solutions Incorporated Cloud-based apparatus, system, and method for sample-testing
US20240066521A1 (en) * 2022-08-25 2024-02-29 Abbott Rapid Diagnostics International Unlimited Company Machine readable diagnostic test devices and methods and apparatus to make and/or process the same
JP7470461B1 (ja) * 2023-02-22 2024-04-18 株式会社イムノセンス 電気化学的手法における被検物質に対する測定の正常性を判定する方法
WO2024196813A2 (en) * 2023-03-17 2024-09-26 Know Labs, Inc. Method of analyzing two analytes within a prescribed time period for medical purposes using an enhanced noninvasive rf analyte detection device
GB2630612B (en) * 2023-05-31 2026-04-29 Eclateral Ltd Lateral flow test systems and methods
CN119224283A (zh) * 2024-10-08 2024-12-31 中船海神医疗科技有限公司 基于胶体金免疫检测原理的食品安全检测设备质控系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358752B1 (en) * 1996-09-27 2002-03-19 Cornell Research Foundation, Inc. Liposome-enhanced test device and method
GB2365526B (en) * 2000-07-31 2003-12-03 Cambridge Life Sciences Assay apparatus for measuring the amount of an analyte in a biological or environmental sample
US7300802B2 (en) * 2003-04-25 2007-11-27 Biodigit Laboratories Corp. Membrane strip biosensor system for point-of-care testing
DK2611042T3 (en) * 2004-01-27 2015-04-20 Altivera L L C DIAGNOSTIC RADIO FREQUENCY IDENTIFICATION SENSORS AND APPLICATIONS THEREOF
GB2437311A (en) * 2006-04-07 2007-10-24 Mologic Ltd A protease detection product
CN101266243B (zh) * 2008-01-31 2012-09-19 程柯 一种用于收集和快速检测口腔液体的仪器
US8815609B2 (en) * 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
JP4722977B2 (ja) * 2008-08-27 2011-07-13 シャープ株式会社 検出器具、分析装置、検出方法および検出器具の制御方法
GB2469071A (en) * 2009-03-31 2010-10-06 Diamatrix Ltd Electrochemical test device
EP2477744A1 (en) * 2009-09-18 2012-07-25 Minifab (Australia) Pty Ltd Instrumented pipette
CN201514408U (zh) * 2009-09-28 2010-06-23 姜学英 一种阴道炎联合检测装置
SG11201508541TA (en) * 2013-04-15 2015-11-27 Univ Nanyang Tech Electrochemical lateral flow bioassay and biosensor
WO2015017591A1 (en) * 2013-07-30 2015-02-05 Express Diagnostics Int'l., Inc. Lateral flow devices and methods of manufacture and use
JP2018091678A (ja) * 2016-12-01 2018-06-14 アークレイ株式会社 分析方法及び分析用具
US11022578B2 (en) * 2018-11-28 2021-06-01 2Pi-Sigma Corp. Lateral flow assay with controlled conjugate time and controlled flow time
EP4031869A1 (en) * 2019-09-20 2022-07-27 Momm Diagnostics GmbH Immunoassay analyzer, immunoassay kit and method for detecting analyte in liquid sample

Also Published As

Publication number Publication date
EP4158342B1 (en) 2026-04-15
WO2021240020A2 (en) 2021-12-02
JP2023527448A (ja) 2023-06-28
US20230221312A1 (en) 2023-07-13
CN116194778A (zh) 2023-05-30
EP4158342A2 (en) 2023-04-05
JP7748972B2 (ja) 2025-10-03
WO2021240020A3 (en) 2022-01-13
KR20230029684A (ko) 2023-03-03

Similar Documents

Publication Publication Date Title
BR112022024278A2 (pt) Dispositivos de teste de diagnóstico legível por máquina e métodos e aparelho para fazer e/ou processar os mesmos
BR112017001444A2 (pt) ?método para detectar pelo menos um analito em uma amostra de teste, elemento sensor, dispositivo de teste, sistema de teste e uso do elemento sensor?
MX2016002632A (es) Dispositivo y metodos para usar un dispositivo para la deteccion de hiperamoniemia.
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
MX373696B (es) Dispositivos, metodos y equipos de prueba para el analisis electronico de analitos.
BR112012024945A2 (pt) sistema e método de medição eletroquímica de analitos
BR112018000851A2 (pt) sistemas e métodos para detecção e quantificação aprimoradas de analitos
EP3578959A3 (en) Method for reading test strips
MX355854B (es) Sistema y metodo para detectar sensores utilizados y secados.
EP4234710A3 (en) Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
MX2022009783A (es) Ensayo de proximidad.
WO2019055661A8 (en) Preeclampsia biomarkers and related systems and methods
MX2020000941A (es) Sistema para analizar resistencia al impacto y perforación.
WO2016085997A3 (en) Determination of fertility potential from the oxidation-reduction potential of a biological sample
MX2016012079A (es) Dispositivo para deteccion de estados de enfermedad y aplicaciones del mismo.
GEP20257829B (en) Salivary biomarkers of brain injury
CN104089838A (zh) 基于硬度的电缆绝缘寿命快速检测方法
BR112021023924A2 (pt) Sistemas e métodos de detecção de um organismo patogênico
BR112017007997A2 (pt) método para determinação de difusão
MX2017002795A (es) Metodo y dispositivo de prueba.
BR112013007679A2 (pt) sistemas e métodos de discriminação entre uma amostra de controle e um fluido de teste usando capacitância
WO2015048696A3 (en) Antimicrobial compound susceptibility test
MX387258B (es) Sistemas y métodos para detección y medición electroquímica de cetona.
WO2014159920A4 (en) A device and method for the detection and diagnosis of aggressive and metastatic cancer and cancer stem cells employing podocalyxin and tra biomarkers
CO2023005605A2 (es) Método para detectar cystoisospora suis